Sociedad Americana de Hirudoterapia

Intramuscular Near-Infrared Spectroscopy for Muscle Flap Monitoring in a Porcine Model

Research article published in Journal of reconstructive microsurgery (2021)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Preclinical (animal)Ensayos clínicosBai W et al. · Journal of reconstructive microsurgery, 2021

Abstract

BACKGROUND:  Current near-infrared spectroscopy (NIRS)-based systems for continuous flap monitoring are limited to flaps which carry a cutaneous paddle. As such, this useful and reliable technology has not previously been applicable to muscle-only free flaps where other modalities with substantial limitations continue to be utilized. METHODS:  We present the first NIRS probe which allows continuous monitoring of local tissue oxygen saturation (StO2) directly within the substance of muscle tissue. This probe is flexible, subcentimeter in scale, waterproof, biocompatible, and is fitted with resorbable barbs which facilitate temporary autostabilization followed by easy atraumatic removal. This novel device was compared with a ViOptix T.Ox monitor in a porcine rectus abdominus myocutaneous flap model of arterial and venous occlusions. During these experiments, the T.Ox device was affixed to the skin paddle, while the novel probe was within the muscle component of the same flap. RESULTS:  The intramuscular NIRS device and skin-mounted ViOptix T.Ox devices produced very similar StO2 tracings throughout the vascular clamping events, with obvious and parallel changes occurring upon vascular clamping and release. The normalized cross-correlation at zero lag describing correspondence between the novel intramuscular NIRS and T.Ox devices was >0.99. CONCLUSION:  This novel intramuscular NIRS probe offers continuous monitoring of oxygen saturation within muscle flaps. This experiment demonstrates the potential suitability of this intramuscular NIRS probe for the task of muscle-only free flap monitoring, where NIRS has not previously been applicable. Testing in the clinical environment is necessary to assess durability and reliability.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsMusclesMyocutaneous FlapOxygenPlastic Surgery ProceduresReproducibility of ResultsSpectroscopy, Near-InfraredSwine

Resumen

Current near-infrared spectroscopy (NIRS)-based systems for continuous flap monitoring are limited to flaps which carry a cutaneous paddle.

Por qué esto importa para la hirudoterapia

Este estudio describe una nueva sonda de espectroscopia de infrarrojo cercano (NIRS) intramuscular para el monitoreo continuo de la saturación tisular de oxígeno dentro de colgajos musculares, evaluada en un modelo porcino de colgajo miocutáneo de recto abdominal que involucró oclusión arterial y venosa. La sonda demostró una alta correlación cruzada con un dispositivo NIRS comercial montado sobre la piel durante eventos de pinzamiento vascular. El resumen no menciona sanguijuelas, hirudina, hirudoterapia ni ningún producto derivado de la sanguijuela, y el estudio aborda tecnología de monitoreo quirúrgico y fisiología de colgajos. No existe un vínculo defendible de relevancia con la sanguijuela para este artículo dentro del dominio de la ASH.

Citación

Intramuscular Near-Infrared Spectroscopy for Muscle Flap Monitoring in a Porcine Model

Bai W et al. · Journal of reconstructive microsurgery, 2021

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.